The number of young people in Australia prescribed medication for attention-deficit hyperactivity disorder (ADHD) increased more that tenfold in 20 years, our new research shows, while it is no longer ...
ADHD prescriptions for Australian children have risen more than tenfold in 20 years, with the wealthiest postcodes now ...
A new model of care is needed to reduce waiting lists for children with attention deficit hyperactivity disorder (ADHD) and other neurodivergent conditions who are often “pushed to the back of the ...
Fabrice Chouraqui, Chief Executive Officer of Pharming, commented: ...
Discusses Positive Phase 3 PROPEL 3 Results for Infigratinib in Children With Achondroplasia February 12, 2026 8:00 ...
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor designed to address the core symptoms of ADHD in children and adults.
General practitioners in Victoria will soon be able to diagnose and treat ADHD in adults and children, in a move the state ...
The Division of Human Development and Disability (DHDD) promotes health equity for people with disabilities of all ages. DHDD ...
Pharming Group receives CRL from US FDA for sNDA for Joenja in children aged 4 to 11 years with APDS
Leiden, the Netherlands Tuesday, February 3, 2026, 18:00 Hrs [IST] ...
New UCSF research reveals that child-parent psychotherapy doesn’t just heal emotional wounds — it repairs a biological process that could benefit kids for life.
Investor's Business Daily on MSN
BridgeBio unveils positive results for its most 'hotly debated' phase 3 drug
BridgeBio unveiled promising results Thursday for its "hotly debated" final-phase asset: a potential treatment for ...
Social anxiety and decision paralysis are sometimes at the end of that continuum.” Related: 11 Subtle Signs You’re Stuck in a ‘Functional Freeze,’ Psychologists Reveal “The ‘dream’ partner for an over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results